SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001398344-23-003358
Filing Date
2023-02-14
Accepted
2023-02-14 15:00:06
Documents
1
Group Members
SESSA CAPITAL (MASTER), L.P., SESSA CAPITAL GP, LLC,SESSA CAPITAL IM, L.P., SESSA CAPITAL IM GP, LLC, JOHN PETRY

Document Format Files

Seq Description Document Type Size
1 fp0082117-5_sc13ga.htm SC 13G/A 95048
  Complete submission text file 0001398344-23-003358.txt   96757
Mailing Address 888 SEVENTH AVENUE 30TH FLOOR NEW YORK NY 10019
Business Address 888 SEVENTH AVENUE 30TH FLOOR NEW YORK NY 10019 212-257-4410
Sessa Capital (Master), L.P. (Filed by) CIK: 0001618360 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 55 BROAD STREET, 2ND FLOOR RED BANK NJ 07701
Business Address 55 BROAD STREET, 2ND FLOOR RED BANK NJ 07701 908-428-9136
Provention Bio, Inc. (Subject) CIK: 0001695357 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90545 | Film No.: 23627623
SIC: 2834 Pharmaceutical Preparations